Susceptibility to seizure-induced injury and acquired microencephaly following intraventricular injection of saporin-conjugated 192 IgG in developing rat brain

Exp Neurol. 2005 Aug;194(2):457-66. doi: 10.1016/j.expneurol.2005.03.002.

Abstract

To study the role of neurotrophin-responsive neurons in brain growth and developmental resistance to seizure-induced injury, we infused saporin-conjugated 192-IgG (192 IgG-saporin), a monoclonal antibody directed at the P75 neurotrophin receptors (p75(NTR)), into the ventricles of postnatal day 8 (P8) rat pups. 7-10 days after immunotoxin treatment, loss of p75(NTR) immunoreactivity was associated with depletion of basal forebrain cholinergic projection to the neocortex and hippocampus. Kainic acid (KA)-induced seizures on P15 resulted in hippocampal neuronal injury in the majority of toxin-treated animals (13/16), but only rarely in saline-injected controls (2/25) (P < 0.001). In addition, widespread cerebral atrophy and a significant decrease in brain weight with preserved body weight were observed. Volumetric analysis of the hippocampal hilar region revealed a 2-fold reduction in perikaryal size and a 1.7-fold increase in cell packing density after 192 IgG-saporin injection. These observations indicate that neurotrophin-responsive neurons including basal forebrain magnocellular cholinergic neurons may be critical for normal brain growth and play a protective role in preventing excitotoxic neuronal injury during development.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Animals, Newborn
  • Antibodies, Monoclonal / pharmacology
  • Atrophy / chemically induced
  • Atrophy / pathology
  • Atrophy / physiopathology*
  • Basal Nucleus of Meynert / drug effects
  • Basal Nucleus of Meynert / pathology
  • Basal Nucleus of Meynert / physiopathology
  • Brain Damage, Chronic / chemically induced
  • Brain Damage, Chronic / pathology
  • Brain Damage, Chronic / physiopathology*
  • Cholinergic Agents / pharmacology
  • Convulsants / pharmacology
  • Disease Models, Animal
  • Disease Susceptibility / physiopathology
  • Epilepsy / chemically induced
  • Epilepsy / complications*
  • Epilepsy / physiopathology
  • Excitatory Amino Acid Agonists / pharmacology
  • Female
  • Immunotoxins / pharmacology
  • Injections, Intraventricular
  • Kainic Acid / pharmacology
  • Male
  • N-Glycosyl Hydrolases
  • Nerve Degeneration / chemically induced
  • Nerve Degeneration / pathology
  • Nerve Degeneration / physiopathology
  • Nerve Growth Factors / metabolism*
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, Nerve Growth Factor / antagonists & inhibitors
  • Receptor, Nerve Growth Factor / metabolism*
  • Ribosome Inactivating Proteins, Type 1
  • Saporins

Substances

  • 192 IgG-saporin
  • Antibodies, Monoclonal
  • Cholinergic Agents
  • Convulsants
  • Excitatory Amino Acid Agonists
  • Immunotoxins
  • Nerve Growth Factors
  • Receptor, Nerve Growth Factor
  • Ribosome Inactivating Proteins, Type 1
  • N-Glycosyl Hydrolases
  • Saporins
  • Kainic Acid